Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Shaare Zedek Medical Center40 enrolled

Overview

Using a virtual reality program in screening and treatment of ADHD.

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group. Parental consent will be obtained.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

ADHD

Interventions

methylphenidateDRUG

Eligibility

Sex: ALLMin age: 10 YearsMax age: 20 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ\>80 Exclusion Criteria: ABNORMAL NEUROLOGICAL STATUS

Locations (1)

Shaari Zedek Pediatric Neurology Unit

Jerusalem, Israel

Outcomes

Primary Outcomes

Virtual Reality program test results

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.